Characteristics | Study population before PSM | Study population after PSM | ||||||
---|---|---|---|---|---|---|---|---|
Total | SR group | RFA group | P-value | Total | SR group | RFA group | P-value | |
Patients | 188 | 103 | 85 | 116 | 58 | 58 | ||
Age, years | 59 (23–82) | 57 (23–82) | 62 (34–81) | 0.006 | 61 (34–82) | 61 (35–82) | 61 (34–80) | 0.788 |
Sex | ||||||||
Male | 130(69.1) | 75 (72.8) | 55 (64.7) | 0.299 | 78 (67.2) | 39 (67.2) | 39 (67.2) | 1 |
Female | 58 (30.9) | 28 (27.2) | 30 (35.3) | 38 (32.8) | 19 (32.8) | 19 (32.8) | ||
BMI | ||||||||
≦ 24 kg/m2 | 93 (49.5) | 50 (48.5) | 43 (50.6) | 0.895 | 59 (50.9) | 29 (50.0) | 30 (51.7) | 1 |
> 24 kg/m2 | 95 (50.5) | 53 (51.5) | 42 (49.4) | 57 (49.1) | 29 (50.0) | 28 (48.3) | ||
Alcohol use | 53 (28.2) | 25 (24.33) | 28 (32.9) | 0.249 | 32 (27.6) | 15 (25.9) | 17 (29.3) | 0.835 |
HBV | ||||||||
Positive | 86 (45.7) | 51 (49.5) | 35 (41.2) | 0.320 | 51 (44.0) | 28 (48.3) | 23 (39.7) | 0.454 |
Negative | 102 (54.3) | 52 (50.5) | 50 (58.8) | 65 (56.0) | 30 (51.7) | 35 (60.3) | ||
HCV | ||||||||
Positive | 91(48.4) | 49 (47.6) | 42 (49.4) | 0.917 | 61 (52.6) | 34 (58.6) | 27 (46.6) | 0.265 |
Negative | 97 (51.6) | 54 (52.4) | 43 (50.6) | 55 (47.4) | 24 (41.4) | 31 (53.4) | ||
Child‐Pugh class A | 179 (95.2) | 100 (97.1) | 79 (92.9) | 0.326 | 113 (97.4) | 56 (96.6) | 57(98.3) | 1 |
Cirrhosis | 115 (61.2) | 54 (52.4) | 61 (71.8) | 0.011 | 72 (62.1) | 36 (62.1) | 36 (62.1) | 1 |
Ascites | 13 (6.9) | 6 (5.8) | 7 (8.2) | 0.719 | 8 (6.9) | 4 (6.9) | 4 (6.9) | 1 |
INR | 1.0 (0.9–1.7) | 1.0 (0.9–1.3) | 1.1 (0.9–1.7) | < 0.001 | 1.0 (0.9–1.7) | 1.0 (0.9–1.3) | 1.0 (0.9–1.7) | 0.382 |
Total bilirubin, mg/dL | 0.9 (0.2–5.4) | 0.8 (0.2–5.4) | 1.1 (0.3–4.2) | 0.001 | 1.0 (0.3–3.9) | 0.8 (0.5–3.9) | 1.1 (0.3–4.2) | 0.785 |
Albumin, g/dL | 4.1 (2.5–4.9) | 4.2 (3.2–4.9) | 4.0 (2.5–4.7) | < 0.001 | 4.1 (2.6–4.9) | 4.1 (3.2–4.9) | 4.0 (2.6–4.6) | 0.051 |
ALBI grade 1 | 166 (88.3) | 97 (94.2) | 69 (81.2) | 0.011 | 102 (87.9) | 53 (91.4) | 49 (84.5) | 0.393 |
AFP > 200 ng/ml | 29 (15.4) | 12 (11.7) | 17 (20.0) | 0.169 | 17 (14.7) | 5 (8.6) | 12 (20.7) | 0.115 |
Tumor size, cm | 1.8 (1.0–2.0) | 1.8 (1.0–2.0) | 1.8 (1.0–2.0) | 0.127 | 1.8(1.0–2.0) | 1.9 (1.0–2.0) | 1.8 (1.0–2.0) | 0.875 |
Mortality | 69 (36.7) | 28 (27.2) | 41 (48.2) | 0.005 | 44 (37.9) | 17 (29.3) | 27 (46.6) | 0.085 |
Recurrence | 79 (42.0) | 43 (41.7) | 36 (42.4) | 1.000 | 49 (42.2) | 25 (43.1) | 24 (41.4) | 1.000 |